Wednesday, April 24, 2024 | Baltimore, MD
Baltimore, MD
Partly Cloudy

Opinion: Congress should act on legislation that helps Md.’s patients and life science economy

July 27, 2022
This was captured well waiting for the doctor who was busy at the time

In the coming weeks, Congress has an opportunity to pass legislation that is intended to improve the lives of millions of patients. The time is at hand for Congress to renew the law creating the FDA prescription drug user fee program, known as “PDUFA.” The reauthorization of this law, which is referred to as PDUFA VII, will help ensure the continued funding of the FDA’s product review activities that enable the approval of the next generation of medicines. Chief among the Marylanders who stand to benefit from PDUFA VII are patients who need new treatments, as well as those employed in our state’s burgeoning life science sector who work at the FDA, biotechnology companies and government-supported labs.


Article Source: Maryland Matters

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.